N-[4-[4-butyl-6-(5-methyl-1H-pyrazol-4-yl)-3-pyridinyl]-5-ethenyl-1H-pyrazol-3-yl]-2-(4-methylpiperazin-1-yl)acetamide;1-(cyclohexen-1-yl)-N-[6-[3-(4-methylpiperazin-1-yl)propoxy]-1H-indazol-5-yl]-1-(5-methyl-1H-pyrazol-4-yl)methanimine;5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;1-methylpiperazine

C76H102N22O3 — CID 162103837

IUPACN-[4-[4-butyl-6-(5-methyl-1H-pyrazol-4-yl)-3-pyridinyl]-5-ethenyl-1H-pyrazol-3-yl]-2-(4-methylpiperazin-1-yl)acetamide;1-(cyclohexen-1-yl)-N-[6-[3-(4-methylpiperazin-1-yl)propoxy]-1H-indazol-5-yl]-1-(5-methyl-1H-pyrazol-4-yl)methanimine;5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;1-methylpiperazine
SMILESC=Cc1[nH]nc(NC(=O)CN2CCN(C)CC2)c1-c1cnc(-c2cn[nH]c2C)cc1CCCC.CCOc1cc2[nH]ncc2c2c3c(c(-c4cn[nH]c4C)nc12)CCCC3.CN1CCNCC1.Cc1[nH]ncc1/C(=N/c1cc2cn[nH]c2cc1OCCCN1CCN(C)CC1)C1=CCCCC1
InChIInChI=1S/C26H35N7O.C25H34N8O.C20H21N5O.C5H12N2/c1-19-22(18-28-30-19)26(20-7-4-3-5-8-20)29-24-15-21-17-27-31-23(21)16-25(24)34-14-6-9-33-12-10-32(2)11-13-33;1-5-7-8-18-13-22(19-15-27-29-17(19)3)26-14-20(18)24-21(6-2)30-31-25(24)28-23(34)16-33-11-9-32(4)10-12-33;1-3-26-17-8-16-15(10-22-25-16)18-12-6-4-5-7-13(12)19(23-20(17)18)14-9-21-24-11(14)2;1-7-4-2-6-3-5-7/h7,15-18H,3-6,8-14H2,1-2H3,(H,27,31)(H,28,30);6,13-15H,2,5,7-12,16H2,1,3-4H3,(H,27,29)(H2,28,30,31,34);8-10H,3-7H2,1-2H3,(H,21,24)(H,22,25);6H,2-5H2,1H3/b29-26+;;;
InChIKeyZFFZNRJWNVLEHQ-PURIYITRSA-N
MW1371.80 g/mol
LogP11.18
Rot. Bonds20

About N-[4-[4-butyl-6-(5-methyl-1H-pyrazol-4-yl)-3-pyridinyl]-5-ethenyl-1H-pyrazol-3-yl]-2-(4-methylpiperazin-1-yl)acetamide;1-(cyclohexen-1-yl)-N-[6-[3-(4-methylpiperazin-1-yl)propoxy]-1H-indazol-5-yl]-1-(5-methyl-1H-pyrazol-4-yl)methanimine;5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;1-methylpiperazine

N-[4-[4-butyl-6-(5-methyl-1H-pyrazol-4-yl)-3-pyridinyl]-5-ethenyl-1H-pyrazol-3-yl]-2-(4-methylpiperazin-1-yl)acetamide;1-(cyclohexen-1-yl)-N-[6-[3-(4-methylpiperazin-1-yl)propoxy]-1H-indazol-5-yl]-1-(5-methyl-1H-pyrazol-4-yl)methanimine;5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;1-methylpiperazine (PubChem CID 162103837) has the molecular formula C76H102N22O3 and a molecular weight of 1371.80 g/mol. Its IUPAC name is N-[4-[4-butyl-6-(5-methyl-1H-pyrazol-4-yl)-3-pyridinyl]-5-ethenyl-1H-pyrazol-3-yl]-2-(4-methylpiperazin-1-yl)acetamide;1-(cyclohexen-1-yl)-N-[6-[3-(4-methylpiperazin-1-yl)propoxy]-1H-indazol-5-yl]-1-(5-methyl-1H-pyrazol-4-yl)methanimine;5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;1-methylpiperazine.

Molecular Properties

Compound NameN-[4-[4-butyl-6-(5-methyl-1H-pyrazol-4-yl)-3-pyridinyl]-5-ethenyl-1H-pyrazol-3-yl]-2-(4-methylpiperazin-1-yl)acetamide;1-(cyclohexen-1-yl)-N-[6-[3-(4-methylpiperazin-1-yl)propoxy]-1H-indazol-5-yl]-1-(5-methyl-1H-pyrazol-4-yl)methanimine;5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;1-methylpiperazine
PubChem CID162103837
Molecular FormulaC76H102N22O3
Molecular Weight1371.80 g/mol
Exact Mass1370.85
IUPAC NameN-[4-[4-butyl-6-(5-methyl-1H-pyrazol-4-yl)-3-pyridinyl]-5-ethenyl-1H-pyrazol-3-yl]-2-(4-methylpiperazin-1-yl)acetamide;1-(cyclohexen-1-yl)-N-[6-[3-(4-methylpiperazin-1-yl)propoxy]-1H-indazol-5-yl]-1-(5-methyl-1H-pyrazol-4-yl)methanimine;5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;1-methylpiperazine
SMILESC=Cc1[nH]nc(NC(=O)CN2CCN(C)CC2)c1-c1cnc(-c2cn[nH]c2C)cc1CCCC.CCOc1cc2[nH]ncc2c2c3c(c(-c4cn[nH]c4C)nc12)CCCC3.CN1CCNCC1.Cc1[nH]ncc1/C(=N/c1cc2cn[nH]c2cc1OCCCN1CCN(C)CC1)C1=CCCCC1
InChIInChI=1S/C26H35N7O.C25H34N8O.C20H21N5O.C5H12N2/c1-19-22(18-28-30-19)26(20-7-4-3-5-8-20)29-24-15-21-17-27-31-23(21)16-25(24)34-14-6-9-33-12-10-32(2)11-13-33;1-5-7-8-18-13-22(19-15-27-29-17(19)3)26-14-20(18)24-21(6-2)30-31-25(24)28-23(34)16-33-11-9-32(4)10-12-33;1-3-26-17-8-16-15(10-22-25-16)18-12-6-4-5-7-13(12)19(23-20(17)18)14-9-21-24-11(14)2;1-7-4-2-6-3-5-7/h7,15-18H,3-6,8-14H2,1-2H3,(H,27,31)(H,28,30);6,13-15H,2,5,7-12,16H2,1,3-4H3,(H,27,29)(H2,28,30,31,34);8-10H,3-7H2,1-2H3,(H,21,24)(H,22,25);6H,2-5H2,1H3/b29-26+;;;
InChIKeyZFFZNRJWNVLEHQ-PURIYITRSA-N
XLogP11.18
TPSA286.01 Ų
H-Bond Donors8
H-Bond Acceptors18
Rotatable Bonds20
Heavy Atoms101
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001371.80
LogP ≤ 511.18
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze N-[4-[4-butyl-6-(5-methyl-1H-pyrazol-4-yl)-3-pyridinyl]-5-ethenyl-1H-pyrazol-3-yl]-2-(4-methylpiperazin-1-yl)acetamide;1-(cyclohexen-1-yl)-N-[6-[3-(4-methylpiperazin-1-yl)propoxy]-1H-indazol-5-yl]-1-(5-methyl-1H-pyrazol-4-yl)methanimine;5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;1-methylpiperazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

1-[3-[6-(difluoromethyl)-7-(1-methylpyrazol-4-yl)-2,3-dihydro-1,4-benzoxazin-4-yl]-1-(oxan-4-yl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-5-yl]ethanone;N-methyl-3-[6-(1-methylpyrazol-4-yl)-3,4-dihydro-2H-1,7-naphthyridin-1-yl]-1-(oxan-4-yl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carboxamide;N-methyl-3-[7-(1-methylpyrazol-4-yl)-6-(trifluoromethyl)-2,3-dihydro-1,4-benzoxazin-4-yl]-1-(oxan-4-yl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carboxamide;1-[3-[7-(1-methylpyrazol-4-yl)-6-(trifluoromethyl)-2,3-dihydro-1,4-benzoxazin-4-yl]-1-(oxan-4-yl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-5-yl]ethanone
CID 158612452
N-[2-[2-[3-[4-[2-methoxy-4-[3-[4-(2-methoxy-5-pyrazin-2-ylanilino)-1H-pyrazolo[5,4-d]pyrimidin-3-yl]-1H-pyrazol-5-yl]-5-phenylanilino]-1H-pyrazolo[5,4-d]pyrimidin-3-yl]-1H-pyrazol-4-yl]ethoxy]-5-pyrimidin-2-ylphenyl]-3-(1H-pyrazol-3-yl)-1H-pyrazolo[5,4-d]pyrimidin-4-amine
CID 132049223
[4-[2-[4-(dimethylamino)-2-methylphenyl]ethenyl]pyridin-1-ium-1-yl]methanol;(3,4-dimethyl-2,3-dihydro-1,4-benzoxazin-7-yl)-(1,2-dimethylpyrazol-1-ium-3-yl)diazene;(1,2-dimethyl-2,3-dihydroindol-5-yl)-(1,2,5-trimethylpyrazol-2-ium-3-yl)diazene;4-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-N,N-dimethylaniline;4-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-N-methylaniline;N,N-dimethyl-4-[2-(1-methylpyridin-1-ium-2-yl)ethenyl]aniline;N,N-dimethyl-4-[2-(1-methylpyridin-1-ium-4-yl)ethenyl]aniline;4-[(2,4-dimethyl-1,2,4-triazol-4-ium-3-yl)diazenyl]aniline;methane;4-methyl-7-[2-(1-methylpyridin-1-ium-4-yl)ethenyl]-2,3-dihydro-1,4-benzoxazine;N'-methyl-N'-[4-[(E)-2-(1-methylpyridin-1-ium-4-yl)ethenyl]phenyl]ethyne-1,2-diamine
CID 157235653
5-[2-(4-methylpiperazin-1-yl)ethoxy]-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;4-[2-[[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-5-yl]oxy]ethyl]morpholine;4-[3-[[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridin-5-yl]oxy]propyl]morpholine
CID 157313320
1-[4-(3-amino-1H-pyrazolo[3,4-c]pyridin-4-yl)naphthalen-1-yl]-3-(2-fluoro-5-methylphenyl)urea;1-[4-(3-amino-1H-pyrazolo[3,4-c]pyridin-4-yl)naphthalen-1-yl]-3-(3-methylphenyl)urea;1-[4-[3-amino-7-(3-pyrrolidin-1-ylpropoxy)-1H-indazol-4-yl]naphthalen-1-yl]-3-(2-fluoro-5-methylphenyl)urea;1-[4-[3-amino-7-(3-pyrrolidin-1-ylpropoxy)-1H-indazol-4-yl]naphthalen-1-yl]-3-(3-methylphenyl)urea
CID 157569593
[4-[(E)-2-[4-(dimethylamino)-2-methylphenyl]ethenyl]pyridin-1-ium-1-yl]methanol;(3,4-dimethyl-2,3-dihydro-1,4-benzoxazin-7-yl)-(1,2-dimethylpyrazol-1-ium-3-yl)diazene;(1,2-dimethyl-2,3-dihydroindol-5-yl)-(1,2,5-trimethylpyrazol-2-ium-3-yl)diazene;4-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-N,N-dimethylaniline;4-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-N-methylaniline;N,N-dimethyl-4-[2-(1-methylpyridin-1-ium-2-yl)ethenyl]aniline;N,N-dimethyl-4-[2-(1-methylpyridin-1-ium-4-yl)ethenyl]aniline;methane;4-methyl-7-[2-(1-methylpyridin-1-ium-4-yl)ethenyl]-2,3-dihydro-1,4-benzoxazine;N'-methyl-N'-[4-[(E)-2-(1-methylpyridin-1-ium-4-yl)ethenyl]phenyl]ethyne-1,2-diamine
CID 157862577
(3,4-dimethyl-2,3-dihydro-1,4-benzoxazin-7-yl)-(1,2-dimethylpyrazol-1-ium-3-yl)diazene;(1,2-dimethyl-2,3-dihydroindol-5-yl)-(1,2,5-trimethylpyrazol-2-ium-3-yl)diazene;4-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-N,N-dimethylaniline;4-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-N-methylaniline;N,N-dimethyl-4-[2-(1-methylpyridin-1-ium-2-yl)ethenyl]aniline;N,N-dimethyl-4-[2-(1-methylpyridin-1-ium-4-yl)ethenyl]aniline;4-[(2,4-dimethyl-1,2,4-triazol-4-ium-3-yl)diazenyl]aniline;4-[2-(1-ethenylpyridin-1-ium-4-yl)ethenyl]-N,N,3-trimethylaniline;methane;3-[N-methyl-4-[2-(1-methylpyridin-1-ium-4-yl)ethenyl]anilino]propanenitrile;4-methyl-7-[2-(1-methylpyridin-1-ium-4-yl)ethenyl]-2,3-dihydro-1,4-benzoxazine;molecular hydrogen;hydrate
CID 158136578
4-methoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;9-(4-methylpiperazin-1-yl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;4-[7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-yl]morpholine;8-(5-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,5-h]quinoline;7-(5-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-f]quinoline
CID 158186414
2-(dimethylamino)-1-[(3R)-3-[3-[(6-ethynyl-8-methoxyquinazolin-2-yl)amino]-5-(1-methylpyrazol-4-yl)phenoxy]pyrrolidin-1-yl]ethanone;N-[3-[(3R)-1-ethylpyrrolidin-3-yl]oxy-5-(1-methylpyrazol-4-yl)phenyl]-6-ethynyl-8-methoxyquinazolin-2-amine;6-(1-methylpyrazol-4-yl)-7-(pyrazin-2-ylmethoxy)-N-[3-(pyrazol-1-ylmethyl)phenyl]quinazolin-2-amine;7-(pyrazin-2-ylmethoxy)-6-(1H-pyrazol-4-yl)-N-[3-(pyrazol-1-ylmethyl)phenyl]quinazolin-2-amine
CID 158306225
[4-[(E)-2-[4-(dimethylamino)-2-methylphenyl]ethenyl]pyridin-1-ium-1-yl]methanol;(3,4-dimethyl-2,3-dihydro-1,4-benzoxazin-7-yl)-(1,2-dimethylpyrazol-1-ium-3-yl)diazene;(1,2-dimethyl-2,3-dihydroindol-5-yl)-(1,2,5-trimethylpyrazol-2-ium-3-yl)diazene;4-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-N,N-dimethylaniline;4-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-N-methylaniline;N,N-dimethyl-4-[2-(1-methylpyridin-1-ium-2-yl)ethenyl]aniline;N,N-dimethyl-4-[2-(1-methylpyridin-1-ium-4-yl)ethenyl]aniline;4-[(2,4-dimethyl-1,2,4-triazol-4-ium-3-yl)diazenyl]aniline;methane;4-methyl-7-[2-(1-methylpyridin-1-ium-4-yl)ethenyl]-2,3-dihydro-1,4-benzoxazine;N'-methyl-N'-[4-[(E)-2-(1-methylpyridin-1-ium-4-yl)ethenyl]phenyl]ethyne-1,2-diamine
CID 158320202
9-tert-butyl-5-cyclohexyl-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;2-methoxy-N-methyl-N-[2-[[9-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8-propyl-6,7-dihydro-3H-pyrazolo[4,3-f]quinolin-5-yl]oxy]ethyl]ethanamine;N-[9-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8-propyl-3H-pyrazolo[4,3-f]quinolin-1-yl]cyclopropanecarboxamide;7-(5-methyl-1H-pyrazol-4-yl)-3a,6,7,8,9,10,11,11c-octahydro-3H-pyrazolo[4,3-a]phenanthridin-5-ol;4-propylmorpholine
CID 158625025
1-[5-(difluoromethoxy)-3-fluoro-2-pyridinyl]-7-methoxy-3-methyl-8-(1-methylpyrazol-4-yl)imidazo[4,5-c]quinolin-2-one;1-(3,5-difluoro-2-pyridinyl)-7-methoxy-3-methyl-8-(5-methyl-1H-pyrazol-4-yl)imidazo[4,5-c]quinolin-2-one;1-(5-ethoxy-3-fluoro-2-pyridinyl)-7-methoxy-3-methyl-8-(1-methylpyrazol-4-yl)imidazo[4,5-c]quinolin-2-one;1-(3-fluoro-5-methoxy-2-pyridinyl)-7-methoxy-8-(1-methylpyrazol-4-yl)-3H-imidazo[4,5-c]quinolin-2-one
CID 158912321

Frequently Asked Questions

What is the IUPAC name of N-[4-[4-butyl-6-(5-methyl-1H-pyrazol-4-yl)-3-pyridinyl]-5-ethenyl-1H-pyrazol-3-yl]-2-(4-methylpiperazin-1-yl)acetamide;1-(cyclohexen-1-yl)-N-[6-[3-(4-methylpiperazin-1-yl)propoxy]-1H-indazol-5-yl]-1-(5-methyl-1H-pyrazol-4-yl)methanimine;5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;1-methylpiperazine?
The IUPAC name of N-[4-[4-butyl-6-(5-methyl-1H-pyrazol-4-yl)-3-pyridinyl]-5-ethenyl-1H-pyrazol-3-yl]-2-(4-methylpiperazin-1-yl)acetamide;1-(cyclohexen-1-yl)-N-[6-[3-(4-methylpiperazin-1-yl)propoxy]-1H-indazol-5-yl]-1-(5-methyl-1H-pyrazol-4-yl)methanimine;5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;1-methylpiperazine (CID 162103837) is N-[4-[4-butyl-6-(5-methyl-1H-pyrazol-4-yl)-3-pyridinyl]-5-ethenyl-1H-pyrazol-3-yl]-2-(4-methylpiperazin-1-yl)acetamide;1-(cyclohexen-1-yl)-N-[6-[3-(4-methylpiperazin-1-yl)propoxy]-1H-indazol-5-yl]-1-(5-methyl-1H-pyrazol-4-yl)methanimine;5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;1-methylpiperazine.
What is the SMILES notation for N-[4-[4-butyl-6-(5-methyl-1H-pyrazol-4-yl)-3-pyridinyl]-5-ethenyl-1H-pyrazol-3-yl]-2-(4-methylpiperazin-1-yl)acetamide;1-(cyclohexen-1-yl)-N-[6-[3-(4-methylpiperazin-1-yl)propoxy]-1H-indazol-5-yl]-1-(5-methyl-1H-pyrazol-4-yl)methanimine;5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;1-methylpiperazine?
The canonical SMILES for N-[4-[4-butyl-6-(5-methyl-1H-pyrazol-4-yl)-3-pyridinyl]-5-ethenyl-1H-pyrazol-3-yl]-2-(4-methylpiperazin-1-yl)acetamide;1-(cyclohexen-1-yl)-N-[6-[3-(4-methylpiperazin-1-yl)propoxy]-1H-indazol-5-yl]-1-(5-methyl-1H-pyrazol-4-yl)methanimine;5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;1-methylpiperazine is C=Cc1[nH]nc(NC(=O)CN2CCN(C)CC2)c1-c1cnc(-c2cn[nH]c2C)cc1CCCC.CCOc1cc2[nH]ncc2c2c3c(c(-c4cn[nH]c4C)nc12)CCCC3.CN1CCNCC1.Cc1[nH]ncc1/C(=N/c1cc2cn[nH]c2cc1OCCCN1CCN(C)CC1)C1=CCCCC1.
What is the InChIKey of N-[4-[4-butyl-6-(5-methyl-1H-pyrazol-4-yl)-3-pyridinyl]-5-ethenyl-1H-pyrazol-3-yl]-2-(4-methylpiperazin-1-yl)acetamide;1-(cyclohexen-1-yl)-N-[6-[3-(4-methylpiperazin-1-yl)propoxy]-1H-indazol-5-yl]-1-(5-methyl-1H-pyrazol-4-yl)methanimine;5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;1-methylpiperazine?
The InChIKey is ZFFZNRJWNVLEHQ-PURIYITRSA-N. The full InChI is InChI=1S/C26H35N7O.C25H34N8O.C20H21N5O.C5H12N2/c1-19-22(18-28-30-19)26(20-7-4-3-5-8-20)29-24-15-21-17-27-31-23(21)16-25(24)34-14-6-9-33-12-10-32(2)11-13-33;1-5-7-8-18-13-22(19-15-27-29-17(19)3)26-14-20(18)24-21(6-2)30-31-25(24)28-23(34)16-33-11-9-32(4)10-12-33;1-3-26-17-8-16-15(10-22-25-16)18-12-6-4-5-7-13(12)19(23-20(17)18)14-9-21-24-11(14)2;1-7-4-2-6-3-5-7/h7,15-18H,3-6,8-14H2,1-2H3,(H,27,31)(H,28,30);6,13-15H,2,5,7-12,16H2,1,3-4H3,(H,27,29)(H2,28,30,31,34);8-10H,3-7H2,1-2H3,(H,21,24)(H,22,25);6H,2-5H2,1H3/b29-26+;;;.
What are the key properties of N-[4-[4-butyl-6-(5-methyl-1H-pyrazol-4-yl)-3-pyridinyl]-5-ethenyl-1H-pyrazol-3-yl]-2-(4-methylpiperazin-1-yl)acetamide;1-(cyclohexen-1-yl)-N-[6-[3-(4-methylpiperazin-1-yl)propoxy]-1H-indazol-5-yl]-1-(5-methyl-1H-pyrazol-4-yl)methanimine;5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;1-methylpiperazine?
N-[4-[4-butyl-6-(5-methyl-1H-pyrazol-4-yl)-3-pyridinyl]-5-ethenyl-1H-pyrazol-3-yl]-2-(4-methylpiperazin-1-yl)acetamide;1-(cyclohexen-1-yl)-N-[6-[3-(4-methylpiperazin-1-yl)propoxy]-1H-indazol-5-yl]-1-(5-methyl-1H-pyrazol-4-yl)methanimine;5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;1-methylpiperazine has a molecular weight of 1371.80 g/mol, XLogP of 11.18, 20 rotatable bonds, 8 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-[4-butyl-6-(5-methyl-1H-pyrazol-4-yl)-3-pyridinyl]-5-ethenyl-1H-pyrazol-3-yl]-2-(4-methylpiperazin-1-yl)acetamide;1-(cyclohexen-1-yl)-N-[6-[3-(4-methylpiperazin-1-yl)propoxy]-1H-indazol-5-yl]-1-(5-methyl-1H-pyrazol-4-yl)methanimine;5-ethoxy-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;1-methylpiperazine is sourced from PubChem (CID 162103837), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).